[Cephalexin in serum, dialysate and urine of patients with renal diseases].
D001681:Biological Assay; D001826:Body Fluids / Q000032:analysis; D002511:Cephalosporins / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D003404:Creatinine / Q000652:urine; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007668:Kidney / Q000187:drug effects; D007671:Kidney Concentrating Ability / Q000187:drug effects; D007674:Kidney Diseases / Q000188:drug therapy*; D010530:Peritoneal Dialysis; D006435:Renal Dialysis; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy
D002511:Cephalosporins; D003404:Creatinine
Cephalexin in Serum, Dialysat und Urin nierengeschädigter Patienten.